Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

Related Articles by Review for PubMed (Select 21568722)

1.

The future of basal insulin supplementation.

Simon AC, DeVries JH.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S103-8. doi: 10.1089/dia.2010.0251. Epub 2011 May 13. Review.

PMID:
21568722
2.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
3.

Hypoglycemia rates with basal insulin analogs.

Little S, Shaw J, Home P.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S53-64. doi: 10.1089/dia.2011.0022. Review.

PMID:
21668338
4.

Insulin preparations with prolonged effect.

Owens DR.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S5-14. doi: 10.1089/dia.2011.0068. Review.

PMID:
21668337
5.

Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.

Bolli GB, Andreoli AM, Lucidi P.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S43-52. doi: 10.1089/dia.2011.0039. Review.

PMID:
21668336
6.

Insulin glargine: a new basal insulin.

Levien TL, Baker DE, White JR Jr, Campbell RK.

Ann Pharmacother. 2002 Jun;36(6):1019-27. Review.

PMID:
12022906
7.

Insulin glargine.

Campbell RK, White JR, Levien T, Baker D.

Clin Ther. 2001 Dec;23(12):1938-57; discussion 1923. Review.

PMID:
11813930
8.

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

Clin Ther. 2005;27 Suppl B:S75-88. Review.

PMID:
16519039
9.
10.

Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.

Owens DR, Bolli GB.

Diabetes Technol Ther. 2008 Oct;10(5):333-49. doi: 10.1089/dia.2008.0023. Review.

PMID:
18715209
11.

Insulin glargine: a new long-acting insulin product.

Reinhart L, Panning CA.

Am J Health Syst Pharm. 2002 Apr 1;59(7):643-9. Review.

PMID:
11944604
12.

Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.

McKeage K, Goa KL.

Treat Endocrinol. 2002;1(1):55-8. Review.

PMID:
15765621
13.

Design of non-standard insulin analogs for the treatment of diabetes mellitus.

Pandyarajan V, Weiss MA.

Curr Diab Rep. 2012 Dec;12(6):697-704. doi: 10.1007/s11892-012-0318-z. Review.

14.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
15.

[New methods in insulin treatment].

Neuwirth G.

Orv Hetil. 2005 Jan 16;146(3):111-6. Review. Hungarian.

PMID:
15693442
16.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
17.

Insulin glargine: long-acting basal insulin analog for improved metabolic control.

Gerich JE.

Curr Med Res Opin. 2004 Jan;20(1):31-7. Review.

PMID:
14741069
18.

Timely initiation of basal insulin.

Riddle MC.

Am J Med. 2004 Feb 2;116 Suppl 3A:3S-9S. Review.

PMID:
15013454
19.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

20.

Clinical strategies for controlling peaks and valleys: type 1 diabetes.

Bolli GB.

Int J Clin Pract Suppl. 2002 Jul;(129):65-74. Review.

PMID:
12166610
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk